The Effect of Intermittent IL-2 Therapy on CD4 T Cells in the Gut in HIV-1 Infected Patients

Ítems similars

• Cycling of Gut Mucosal CD4+ T Cells Decreases after Prolonged Anti-Retroviral Therapy and is Associated with Plasma LPS Levels
  per: Ciccone, Emily J., et al.
  Publicat: (2009)
• Lack of Compartmentalization of HIV-1 Quasispecies Between the Gut and Peripheral Blood Compartments
  per: Imamichi, Hiromi, et al.
  Publicat: (2011)
• CD4(+) T Cells, Including Th17 and Cycling Subsets, Are Intact in the Gut Mucosa of HIV-1-Infected Long-Term Nonprogressors
  per: Ciccone, Emily J., et al.
  Publicat: (2011)
• CD4 T Cell Survival Following Intermittent IL-2 Therapy is Predictive of Increase in CD4 T Cell Count in HIV-Infected Patients
  per: Read, Sarah W., et al.
  Publicat: (2008)
• Induction of prolonged survival of CD4(+) T lymphocytes by intermittent IL-2 therapy in HIV-infected patients
  per: Kovacs, Joseph A., et al.
  Publicat: (2005)